Financing, Equity Capital Markets

Madrigal Pharmaceuticals, Inc.

09/23
|
$499.9 Million
Magrigal
Piper Sandler served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Biopharma